4. Results of sensitivity network meta‐analysis for outcome total number of skeletal‐related events (sensitivity risk of bias). Prediction intervals. Treatments are ordered by P‐score (descending). Only subnetworks with > 1 design.

95% prediction intervals (risk ratios, random‐effects model)
Denosumab	[ 0.88, 1.45 ]	[ 0.71, 1.96 ]	[ 0.19, 8.21 ]	[ 0.89, 1.84 ]
[ 0.69, 1.14 ]	Zoledronic acid	[ 0.67, 1.62 ]	[ 0.17, 7.14 ]	[ 0.87, 1.47 ]
[ 0.51, 1.41 ]	[ 0.62, 1.49 ]	Clodronate	[ 0.16, 6.95 ]	[ 0.75, 1.55 ]
[ 0.12, 5.38 ]	[ 0.14, 5.98 ]	[ 0.14, 6.34 ]	Risedronate	[ 0.16, 6.62 ]
[ 0.54, 1.13 ]	[ 0.68, 1.15 ]	[ 0.64, 1.33 ]	[ 0.15, 6.21 ]	No treatment/placebo